DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Evaluating the potential of non-immunosuppressive cyclosporin analogs for targeting Toxoplasma gondii cyclophilin: Insights from structural studies
16 pags., 7 figs., 1 tab., Toxoplasmosis persists as a prevalent disease, facing challenges from parasite resistance and treatment side effects. Consequently, identifying new drugs by exploring novel protein targets is essential for effective intervention. Cyclosporin A (CsA) possesses antiparasitic activity against Toxoplasma gondii, with cyclophilins identified as possible targets. However, CsA immunosuppressive nature hinders its use as an antitoxoplasmosis agent. Here, we evaluate the potential of three CsA derivatives devoid of immunosuppressive activity, namely, NIM811, Alisporivir, and dihydrocyclosporin A to target a previously characterized cyclophilin from Toxoplasma gondii (TgCyp23). We determined the X-ray crystal structures of TgCyp23 in complex with the three analogs and elucidated their binding and inhibitory properties. The high resolution of the structures revealed the precise positioning of ligands within the TgCyp23 binding site and the details of protein-ligand interactions. A comparison with the established ternary structure involving calcineurin indicates that substitutions at position 4 in CsA derivatives prevent calcineurin binding. This finding provides a molecular explanation for why CsA analogs can target Toxoplasma cyclophilins without compromising the human immune response., This study has been funded by a grant 2023 from theEuropean Society of Clinical Microbiology and Infectious Diseases (Europäische Gesellschaft für klinische Mikro-biologie und Infektionskrankheiten) (ESCMID) to F.F.We also acknowledge financial support under the National Recovery and Resiliance Plan (NRRP), Mission4, Component 2, Investment 1.1 Call for tender No. 1409 published on 14.09.2022 by the Italian Ministry of University and Research (MUR), funded by the EuropeanUnion—NextGenerationEU- Project title “Identificationof isoform-specific cyclosporin based inhibitors as noveltherapeutic molecules against toxoplasmosis” - CUPB53D23033240001-Grant Assignment Decree No. 1364adopted on 1/09/2023 by the Italian Ministry of Univer-sity and Research (MUR). The research was also sup-ported by departmental funds provided by the ItalianMinistry of University and Research (FUR2022,FUR2023) to A.A. The work in Spain was funded bygrants PID2020-115331GB-100 and PID2023-153118OB-100 from the Spanish Ministry of Science and Innovationto J.A.H. We thank the staff of beamline XALOC atALBA synchrotron for support in data collection. TheCentro Piattaforme Tecnologiche of the University of Verona is also acknowledged for providing access to thespectroscopic platform. Open access publishing facilitatedby Universita degli Studi di Verona, as part of the Wiley -CRUI-CARE agreement, Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-115331GB-I00
,
AEI PID2023-153118OB-100
DOI: http://hdl.handle.net/10261/372997, https://api.elsevier.com/content/abstract/scopus_id/85204759813
HANDLE: http://hdl.handle.net/10261/372997, https://api.elsevier.com/content/abstract/scopus_id/85204759813